Is BSX up or down today?
BSX is down 1.85% today, last at 43.50. This stock moved -1.85% versus the prior close.
BSX · Boston Scientific
BSX (Boston Scientific) is trading at 43.50, down 1.85% on the session. BSX sits at the 6% mark of its 52-week range, carries a 14-day RSI of 47, and trades below its 50-day average. Over the past month it is up 2.59%.
Leading the coverage: “Mizuho Securities Adjusts Boston Scientific Price Target to $50 From $55” (MT Newswires, 5d ago). BSX is +2.52% since story.
BSX trades on a trailing P/E of 17.5 and is running 5.23% ahead of the S&P 500 over the same stretch.
Analyst firms are mostly reiterating — no strong directional shift lately.
BSX is down 1.85% today, last at 43.50. This stock moved -1.85% versus the prior close.
Leading the coverage: “Mizuho Securities Adjusts Boston Scientific Price Target to $50 From $55” (MT Newswires, 5d ago). BSX is +2.52% since story. Dominant story: Is BSX Worth Buying Now as Low Valuation Meets Weak Earnings Growth? - The Globe and Mail (3 sources, bearish) RSI is 47 — neutral Price below 50-day average — short-term weakness Social sentiment loads separately — see the Social tab.
Analyst firms are mostly reiterating — no strong directional shift lately.
Loaded: May 2026 – Nov 2026 (125 days) · Drag or scroll left for earlier dates
Is BSX Worth Buying Now as Low Valuation Meets Weak Earnings Growth? - The Globe and Mail
Form 4 Boston Scientific Corp: Miriam O’Sullivan (SVP, Chief HR Officer) For: 1 November By Investing.com - Investing.com India
HR chief Miriam O'Sullivan acquires 3,871 Boston Scientific (BSX) shares; spouse holds 1,731. - Stock Titan
Butterfield shares slide on BSX and NYSE - Royal Gazette | Bermuda
Is BSX Worth Buying Now as Low Valuation Meets Weak Earnings Growth?